Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France-Reference-Cited by-同舟云学术

Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France

Published:2018-01-09 Issue:2 Volume:10 Page:210-221
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Martin Camille¹,Kizlik-Masson Claire²,Pèlegrin André³,Watier Hervé²⁴,Viaud-Massuard Marie-Claude¹,Joubert Nicolas¹

Affiliation:

1. Equipe 4 IMT GICC, Université François Rabelais, Tours, France

2. Equipe 1 FRAME GICC, Université François Rabelais, Tours, France

3. IRCM, Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France

4. Service d'Immunologie, CHRU de Tours, Tours, France

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1412130

Reference35 articles.

1. Strategies and challenges for the next generation of antibody–drug conjugates

2. Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates

3. A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity

4. A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study;Frontiers in Pharmacology;2022-06-20

2. Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases;Bioorganic & Medicinal Chemistry;2022-05

3. A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody–Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors;Molecular Cancer Therapeutics;2022-02-07

4. Drug resistance problems in chemotherapy;Nanocarriers for Drug-Targeting Brain Tumors;2022

5. Tetrapeptide ligands screening for antibody separation and purification by molecular simulation and experimental verification;Biochemical Engineering Journal;2021-12